A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations

Clinical trial NCT07612657 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07612657
Sponsor: VIVUS LLC
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Arterial Hypertension Pulmonary Arterial Hypertension (PAH)Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH)Pulmonary Arterial Hypertension PAH Pulmonary Arterial Hypertension WHO Group I

Start date: 2026-05-29
Primary completion: 2028-05-31
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.